Published in Pharmacogenet Genomics on September 01, 2015
Promoter polymorphism (-590, T/C) of interleukin 4 (IL4) gene is associated with rheumatoid arthritis: An updated meta-analysis. Saudi J Biol Sci (2016) 0.75
Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis. Pharmacogenomics J (2017) 0.75
Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi. Cell (2003) 3.75
The genome of Tetranychus urticae reveals herbivorous pest adaptations. Nature (2011) 3.29
Criteria for Guillain-Barré syndrome: additional insights from clinico-pathological studies. Clin Neurophysiol (2012) 2.49
Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (2005) 2.06
Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery. Rheumatology (Oxford) (2009) 2.00
Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain (2005) 1.63
Response to a urate-lowering diet according to polymorphisms in the apolipoprotein AI-CIII-AIV cluster. J Rheumatol (2005) 1.53
BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis. J Rheumatol (2013) 1.50
EpiReumaPt- the study of rheumatic and musculoskeletal diseases in Portugal: a detailed view of the methodology. Acta Reumatol Port (2015) 1.43
The Portuguese Society of Rheumatology position paper on the use of biosimilars. Acta Reumatol Port (2014) 1.42
Vulnerable carina anatomy and ostial lesions in the left anterior descending coronary artery after floating-stent treatment. Rev Esp Cardiol (2009) 1.39
Ultrasound findings during percutaneous treatment of bifurcated coronary lesions. Rev Esp Cardiol (2008) 1.38
Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis (2011) 1.35
Osteoblasts and bone formation. Acta Reumatol Port (2007) 1.34
Type II phosphatidylinositol 4-kinase beta is a cytosolic and peripheral membrane protein that is recruited to the plasma membrane and activated by Rac-GTP. J Biol Chem (2002) 1.33
Application of the Teager-Kaiser energy operator in bearing fault diagnosis. ISA Trans (2013) 1.30
The DOF protein, SAD, interacts with GAMYB in plant nuclei and activates transcription of endosperm-specific genes during barley seed development. Plant J (2005) 1.27
Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis. Arthritis Res Ther (2010) 1.25
Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5. Arch Intern Med (2002) 1.10
Lipid raft adhesion receptors and Syk regulate selectin-dependent rolling under flow conditions. Blood (2006) 1.07
ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology (Oxford) (2011) 1.07
SAD: a new DOF protein from barley that activates transcription of a cathepsin B-like thiol protease gene in the aleurone of germinating seeds. Plant J (2003) 1.02
Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine. Joint Bone Spine (2008) 1.02
Expression of a barley cystatin gene in maize enhances resistance against phytophagous mites by altering their cysteine-proteases. Plant Cell Rep (2010) 1.02
Whole blood transcriptional profiling in ankylosing spondylitis identifies novel candidate genes that might contribute to the inflammatory and tissue-destructive disease aspects. Arthritis Res Ther (2011) 1.01
Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα. Arthritis Res Ther (2015) 1.00
Hypertonic stress increases phosphatidylinositol 4,5-bisphosphate levels by activating PIP5KIbeta. J Biol Chem (2006) 1.00
Comparison of a dipstick assay for detection of Brucella-specific immunoglobulin M antibodies with other tests for serodiagnosis of human brucellosis. Clin Diagn Lab Immunol (2003) 1.00
Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection. PLoS One (2012) 1.00
Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum (2010) 0.97
A barley cysteine-proteinase inhibitor reduces the performance of two aphid species in artificial diets and transgenic Arabidopsis plants. Transgenic Res (2010) 0.97
[Meta-analysis of efficacy of anti-TNF alpha therapy in ankylosing spondylitis patients]. Reumatol Clin (2008) 0.97
Bilateral MR imaging of the hand and wrist in early and very early inflammatory arthritis: tenosynovitis is associated with progression to rheumatoid arthritis. Radiology (2012) 0.96
First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early). Rheumatology (Oxford) (2009) 0.96
Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children. J Rheumatol (2006) 0.94
Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation. J Neurol (2011) 0.93
Investigation of the IL23R gene in a Spanish rheumatoid arthritis cohort. Hum Immunol (2007) 0.93
Cysteine peptidases and their inhibitors in Tetranychus urticae: a comparative genomic approach. BMC Genomics (2012) 0.92
Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis. Arthritis Rheum (2002) 0.92
Alterations on peripheral blood B-cell subpopulations in very early arthritis patients. Rheumatology (Oxford) (2010) 0.92
Molecular basis of leukocyte rolling on PSGL-1. Predominant role of core-2 O-glycans and of tyrosine sulfate residue 51. J Biol Chem (2002) 0.91
Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur J Endocrinol (2002) 0.91
Study of functional variants of the BANK1 gene in rheumatoid arthritis. Arthritis Rheum (2009) 0.91
Cognitive-behavioral therapy for insomnia and sleep hygiene in fibromyalgia: a randomized controlled trial. J Behav Med (2013) 0.91
Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J Rheumatol (2011) 0.90
[Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]. Acta Reumatol Port (2006) 0.90
Structural and functional diversity within the cystatin gene family of Hordeum vulgare. J Exp Bot (2006) 0.90
Thermal degradation of allicin in garlic extracts and its implication on the inhibition of the in-vitro growth of Helicobacter pylori. Biotechnol Prog (2004) 0.90
Chronic arthritis leads to disturbances in the bone collagen network. Arthritis Res Ther (2010) 0.90
Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression. Clin Rev Allergy Immunol (2014) 0.89
HvMCB1, a R1MYB transcription factor from barley with antagonistic regulatory functions during seed development and germination. Plant J (2006) 0.89
Allyl-thiosulfinates, the bacteriostatic compounds of garlic against Helicobacter pylori. Biotechnol Prog (2004) 0.89
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter. Arthritis Res Ther (2007) 0.89
Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk. PLoS One (2012) 0.88
Primary biliary cirrhosis in a rheumatoid arthritis patient treated with rituximab, a case-based review. Clin Rheumatol (2011) 0.88
Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immunol (2007) 0.87
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 update. Acta Reumatol Port (2012) 0.87
Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival. Rheumatology (Oxford) (2010) 0.87
New insights into the pathophysiology of pes cavus in Charcot-Marie-Tooth disease type 1A duplication. J Neurol (2011) 0.87
A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: the Esperanza Program. Ann Rheum Dis (2011) 0.86
A cathepsin F-like peptidase involved in barley grain protein mobilization, HvPap-1, is modulated by its own propeptide and by cystatins. J Exp Bot (2012) 0.86
Gynecomastia and sexual impotence associated with methotrexate treatment. J Rheumatol (2002) 0.86
Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. PLoS One (2011) 0.85
Gene pyramiding of peptidase inhibitors enhances plant resistance to the spider mite Tetranychus urticae. PLoS One (2012) 0.85
[Atrial hematoma in cardiac postoperative patients and the diagnostic use of transesophageal echocardiography]. Rev Esp Cardiol (2002) 0.85
Patterns of use and dosing of tocilizumab in the treatment of patients with rheumatoid arthritis in routine clinical practice: the ACT-LIFE study. Rheumatol Int (2015) 0.84
Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes. Endocr Relat Cancer (2011) 0.84
Low osteocalcin/collagen type I bone gene expression ratio is associated with hip fragility fractures. Bone (2012) 0.84
Work disability in patients with ankylosing spondylitis. J Rheumatol (2009) 0.84
A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer. PLoS One (2012) 0.84
Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication. Muscle Nerve (2003) 0.84
Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile. BMC Med (2013) 0.83
MYO9B gene polymorphisms are associated with autoimmune diseases in Spanish population. Hum Immunol (2007) 0.83
Association of the intergenic single-nucleotide polymorphism rs10865331 (2p15) with ankylosing spondylitis in a Spanish population. J Rheumatol (2010) 0.83
Effects of myofascial release after high-intensity exercise: a randomized clinical trial. J Manipulative Physiol Ther (2008) 0.83
Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritis. J Rheumatol (2009) 0.83
Dynamic contrast-enhanced 3-T magnetic resonance imaging: a method for quantifying disease activity in early polyarthritis. Skeletal Radiol (2011) 0.82
Charcot–Marie–Tooth disease type 2J with MPZ Thr124Met mutation: clinico-electrophysiological and MRI study of a family. J Neurol (2009) 0.82
Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs? BMC Med (2013) 0.82
Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats. Hypertension (2003) 0.82
Fine mapping of a major histocompatibility complex in ankylosing spondylitis: association of the HLA-DPA1 and HLA-DPB1 regions. Arthritis Rheum (2011) 0.82
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. Int J Cancer (2014) 0.82
Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation. J Neurol (2008) 0.82
[Protocol for evaluation and monitoring of Systemic Lupus Erythematosus (PAMLES)]. Acta Reumatol Port (2008) 0.81
To B or not to B the conductor of rheumatoid arthritis orchestra. Clin Rev Allergy Immunol (2012) 0.81
Osteoporosis: from bone biology to individual treatment decision. Acta Med Port (2013) 0.81
Persistent low grade synovitis without erosive progression in magnetic resonance imaging of rheumatoid arthritis patients treated with infliximab over 1 year. Clin Rheumatol (2009) 0.81
Phenotypic differences between familial versus sporadic ankylosing spondylitis: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER). Clin Exp Rheumatol (2011) 0.81
Lymphotoxin-α 252 A>G polymorphism: a link between disease susceptibility and dyslipidemia in rheumatoid arthritis? J Rheumatol (2011) 0.81
A high density SNP genotyping approach within the 19q13 chromosome region identifies an association of a CNOT3 polymorphism with ankylosing spondylitis. Ann Rheum Dis (2012) 0.81